40. Takayasu arteritis Clinical trials / Disease details


Clinical trials : 25 Drugs : 50 - (DrugBank : 21) / Drug target genes : 25 - Drug target pathways : 114

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04882072
(ClinicalTrials.gov)
September 15, 202110/5/2021A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Participants With Takayasu ArteritisTakayasu ArteritisDrug: Ustekinumab;Other: Placebo;Drug: Glucorticoid Taper RegimenJanssen Pharmaceutical K.K.NULLRecruiting18 Years75 YearsAll50Phase 3Japan